Kolkata-based Suraksha Diagnostic is launching an offer for sale worth ₹846 crore, giving partial exit to OrbiMed Asia and reducing promoter holding. The company operates primarily in West Bengal and plans to expand its services and markets. The IPO values it at 73.5 times its annualized FY25 earnings. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
